Skip to main content
Journal cover image

Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.

Publication ,  Journal Article
Figtree, GA; Redfors, B; Kozor, R; Vernon, ST; Grieve, SM; Mazhar, J; Thiele, H; Patel, MR; Udelson, JE; Selker, HP; Ohman, EM; Maehara, A ...
Published in: JACC Cardiovasc Interv
June 13, 2022

BACKGROUND: The author recently reported ∼50% excess early mortality in patients with first-presentation ST-segment elevation myocardial infarction (STEMI) without standard modifiable cardiovascular risk factors (SMuRFs); the cause of this is not clear. OBJECTIVES: The aim of this study was to examine differences in infarct characteristics and clinical outcomes in patients with versus without SMuRFs (dyslipidemia, hypertension, diabetes mellitus, and smoking). METHODS: Individual-level data were pooled from 10 randomized percutaneous intervention (PCI) trials in which infarct size was measured within 1 month by either cardiac magnetic resonance or technetium-99m sestamibi single-photon emission computed tomography imaging. First-presentation STEMI was classified into 2 groups according to the presence or absence of at least 1 SMuRF. RESULTS: Among 2,862 patients, 524 (18.3%) were SMuRF-less. After adjusting for study effect, SMuRF-less patients had more frequent poor pre-PCI flow Thrombolysis In Myocardial Infarction 0/1 compared with patients with at least 1 SMuRF (72.0% vs 64.1%; OR: 1.35; 95% CI: 1.08-1.70). There were no independent associations between the presence or absence of SMuRFs at baseline and infarct size (estimate = -0.35; 95% CI: -1.93 to 1.23), left ventricular ejection fraction (estimate = -0.06; 95% CI: -1.33 to 1.20), or mortality at 30 days (HR: 0.46; 95% CI: 0.19-1.07) and 1 year (HR: 0.74; 95% CI: 0.43-1.29). CONCLUSIONS: First-presentation STEMI patients with no identifiable baseline SMuRFs had a higher risk of Thrombolysis In Myocardial Infarction flow grade 0/1 pre-PCI. However, after adjustment, there were no significant associations between SMuRF-less status and infarct size, left ventricle ejection fraction, or mortality.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

June 13, 2022

Volume

15

Issue

11

Start / End Page

1167 / 1175

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Treatment Outcome
  • Stroke Volume
  • ST Elevation Myocardial Infarction
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Humans
  • Heart Disease Risk Factors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Figtree, G. A., Redfors, B., Kozor, R., Vernon, S. T., Grieve, S. M., Mazhar, J., … Kosmidou, I. (2022). Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors. JACC Cardiovasc Interv, 15(11), 1167–1175. https://doi.org/10.1016/j.jcin.2022.03.036
Figtree, Gemma A., Bjorn Redfors, Rebecca Kozor, Stephen T. Vernon, Stuart M. Grieve, Jawad Mazhar, Holger Thiele, et al. “Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.JACC Cardiovasc Interv 15, no. 11 (June 13, 2022): 1167–75. https://doi.org/10.1016/j.jcin.2022.03.036.
Figtree GA, Redfors B, Kozor R, Vernon ST, Grieve SM, Mazhar J, et al. Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors. JACC Cardiovasc Interv. 2022 Jun 13;15(11):1167–75.
Figtree, Gemma A., et al. “Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.JACC Cardiovasc Interv, vol. 15, no. 11, June 2022, pp. 1167–75. Pubmed, doi:10.1016/j.jcin.2022.03.036.
Figtree GA, Redfors B, Kozor R, Vernon ST, Grieve SM, Mazhar J, Thiele H, Patel MR, Udelson JE, Selker HP, Ohman EM, Maehara A, Karmpaliotis D, Eitel I, Granger CB, Ben-Yehuda O, Stone GW, Kosmidou I. Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors. JACC Cardiovasc Interv. 2022 Jun 13;15(11):1167–1175.
Journal cover image

Published In

JACC Cardiovasc Interv

DOI

EISSN

1876-7605

Publication Date

June 13, 2022

Volume

15

Issue

11

Start / End Page

1167 / 1175

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • Treatment Outcome
  • Stroke Volume
  • ST Elevation Myocardial Infarction
  • Risk Factors
  • Randomized Controlled Trials as Topic
  • Percutaneous Coronary Intervention
  • Myocardial Infarction
  • Humans
  • Heart Disease Risk Factors